The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cefixime 200 mg film-coated tablets

Orchid Europe LimitedPA1335/002/001

Main Information

Trade NameCefixime 200 mg film-coated tablets
Active SubstancesCefixime
Dosage FormFilm-coated tablet
Licence HolderOrchid Europe Limited
Licence NumberPA1335/002/001

Group Information



License statusAuthorised
Licence Issued15/10/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back